https://www.selleckchem.com/pr....oducts/eidd-2801.htm
Purpose To evaluate the effects of a coexisting epiretinal membrane (ERM) on the treatment outcomes of a dexamethasone implant (DI) in diabetic macular edema (DME) patients. Methods One hundred five eyes of 78 DME patients (44 F, 34 M; mean age 65.7) treated with minimum 2 DIs were enrolled into this retrospective study. The study population was divided into the ERM (+) study group and the ERM (-) control group. The best corrected visual acuity (BCVA), intraocular pressure, and central macular thicknesses (CMTs) were evaluated at base
Like
Comment
Share
